Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type IV alpha 5 chain | 0.553 | 0.654 | 1.00 |
|
group | 0.440 | strong | 1.000 | 0 | 0 | 2011 | 2018 | ||||||||
|
LIM homeobox transcription factor 1 beta | 0.565 | 0.731 | 0.75 |
|
group | 0.420 | limited | 1.000 | 0 | 0 | 2002 | 2014 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
group | 0.420 | limited | 1.000 | 0 | 0 | 2006 | 2007 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
group | 0.400 | strong | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1 | 0.599 | 0.654 | 2.3E-06 |
|
group | 0.400 | limited | 0 | 0 | |||||||||||
|
inverted formin, FH2 and WH2 domain containing | 0.644 | 0.423 | 0.97 |
|
group | 0.340 | strong | 1.000 | 0 | 0 | 2011 | 2015 | ||||||||
|
NPHS2 stomatin family member, podocin | 0.576 | 0.538 | 7.2E-09 |
|
group | 0.340 | strong | 1.000 | 0 | 0 | 2003 | 2013 | ||||||||
|
collagen type IV alpha 3 chain | 0.552 | 0.692 | 1.1E-12 |
|
group | 0.320 | strong | 1.000 | 0 | 0 | 2007 | 2017 | ||||||||
|
chloride voltage-gated channel 5 | 0.593 | 0.577 | 0.99 |
|
group | 0.310 | strong | 1.000 | 0 | 0 | 2020 | 2020 | ||||||||
|
collagen type IV alpha 4 chain | 0.644 | 0.500 | 6.7E-16 |
|
group | 0.310 | strong | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
crumbs cell polarity complex component 2 | 0.678 | 0.269 | 1.5E-14 |
|
group | 0.300 | moderate | 0 | 0 | |||||||||||
|
uromodulin | 0.520 | 0.846 | 3.1E-17 |
|
group | 0.300 | strong | 0 | 0 | |||||||||||
|
solute carrier family 12 member 3 | 0.493 | 0.808 | 3.0E-32 |
|
group | 0.300 | strong | 0 | 0 | |||||||||||
|
spalt like transcription factor 1 | 0.539 | 0.808 | 1.00 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||
|
phospholipase C epsilon 1 | 0.572 | 0.654 | 5.7E-11 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||
|
paired box 2 | 0.495 | 0.731 | 0.67 |
|
group | 0.300 | strong | 0 | 0 | |||||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
group | 0.300 | strong | 0 | 0 | |||||||||||
|
NPHS1 adhesion molecule, nephrin | 0.597 | 0.615 | 2.5E-14 |
|
group | 0.300 | moderate | 0 | 0 | |||||||||||
|
nephrocystin 3 | 0.597 | 0.654 | 9.8E-16 |
|
group | 0.300 | strong | 0 | 0 | |||||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||
|
anosmin 1 | 0.537 | 0.769 | 1.00 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
group | 0.300 | limited | 0 | 0 |